Cargando…
Prognostic Potential of Alternative Splicing Markers in Endometrial Cancer
Alternative splicing (AS), an important post-transcriptional regulatory mechanism that regulates the translation of mRNA isoforms and generates protein diversity, has been widely demonstrated to be associated with oncogenic processes. In this study, we systematically analyzed genome-wide AS patterns...
Autores principales: | Wang, Qian, Xu, Teng, Tong, Yu, Wu, Jianbo, Zhu, Weijian, Lu, Zhongqiu, Ying, Jianchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889075/ https://www.ncbi.nlm.nih.gov/pubmed/31785579 http://dx.doi.org/10.1016/j.omtn.2019.10.027 |
Ejemplares similares
-
Novel miRNA markers for the diagnosis and prognosis of endometrial cancer
por: Wang, Qian, et al.
Publicado: (2020) -
Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
por: Chen, Peigen, et al.
Publicado: (2020) -
Establishment of a nine‐gene prognostic model for predicting overall survival of patients with endometrial carcinoma
por: Ying, Jianchao, et al.
Publicado: (2018) -
Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer
por: Wang, Caixia, et al.
Publicado: (2019) -
Analysis of Prognostic Alternative Splicing Reveals the Landscape of Immune Microenvironment in Thyroid Cancer
por: Wu, Jian, et al.
Publicado: (2021)